Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammation after photodynamic therapy of actinic keratoses
2011-005984-25Phase 2Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Feb 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methyl aminolevulinate and clobetasol in actinic keratosis (AK) (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: redness after treatment. Started Feb 2012; status: terminated.
02
Drugs
methyl aminolevulinateclobetasol
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2011-005984-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005984-25.